1-20 of 84
Thomas R. Collins
Close
Sort by
News

Daratumumab-Containing Quadruplet Effective as First-Line in Transplant-Ineligible NDMM, Randomized Trial Finds

Thomas R. Collins
Published: 2025
Abstract
May 2025
View News titled, Daratumumab-Containing Quadruplet Effective as First-Line in Transplant-Ineligible NDMM, Randomized Trial Finds
News

Lenalidomide Maintenance Discontinuation a Viable Option for Some Patients With MM

Thomas R. Collins
Published: 2025
Abstract
May 2025
View News titled, Lenalidomide Maintenance Discontinuation a Viable Option for Some Patients With MM
News

Short-Term Benefit Seen With Tranexamic Acid in Hemarthrosis, but Questions Persist

Thomas R. Collins
Published: 2025
Abstract
April 2025
View News titled, Short-Term Benefit Seen With Tranexamic Acid in Hemarthrosis, but Questions Persist
News

New Tool Aims to Improve Capture of Patient Outcomes in cGVHD-Associated Sclerosis

Thomas R. Collins
Published: 2025
Abstract
April 2025
View News titled, New Tool Aims to Improve Capture of Patient Outcomes in cGVHD-Associated Sclerosis
News

Telemedicine Approach Helps Improve IC-Based SCD Pain Management

Thomas R. Collins
Published: 2025
Abstract
March 2025
View News titled, Telemedicine Approach Helps Improve IC-Based SCD Pain Management
News

Teclistamab Safe for Treating Patients with R/R MM with Renal Impairment

Thomas R. Collins
Published: 2025
Abstract
April 2025
View News titled, Teclistamab Safe for Treating Patients with R/R MM with Renal Impairment
News

Extramedullary Disease Helps Predict Immune Effector Cell Toxicities After CAR-T in MM

Thomas R. Collins
Published: 2025
Abstract
April 2025
View News titled, Extramedullary Disease Helps Predict Immune Effector Cell Toxicities After CAR-T in MM
News

Physical Function Can Help Gauge ICANS Risk, Study Finds

Thomas R. Collins
Published: 2025
Abstract
April 2025
View News titled, Physical Function Can Help Gauge ICANS Risk, Study Finds
News

Multimodal Machine Learning Boosts CAR-T Outcome Prediction in LBCL

Thomas R. Collins
Published: 2025
Abstract
April 2025
View News titled, Multimodal Machine Learning Boosts CAR-T Outcome Prediction in LBCL
News

IL-15 Agonist Boosts Response in Phase II LBCL CAR-T Trial

Thomas R. Collins
Published: 2025
Abstract
February 2025
View News titled, IL-15 Agonist Boosts Response in Phase II LBCL CAR-T Trial
News

CAR-T Produces Good Long-Term Outcomes in R/R CLL, Analysis Finds

Thomas R. Collins
Published: 2024
Abstract
January 2025
View News titled, CAR-T Produces Good Long-Term Outcomes in R/R CLL, Analysis Finds
News

Ibrutinib-Rituximab Outperforms Chemotherapy in Front-Line MCL, Trial Finds

Thomas R. Collins
Published: 2024
Abstract
January 2025
View News titled, Ibrutinib-Rituximab Outperforms Chemotherapy in Front-Line MCL, Trial Finds
News

Eliminating Modifiable Risk Factors Lowers Bleeding Risk in Patients With Cancer, VTE, Study Finds

Thomas R. Collins
Published: 2024
Abstract
January 2025
View News titled, Eliminating Modifiable Risk Factors Lowers Bleeding Risk in Patients With Cancer, VTE, Study Finds
News

Considerable Morbidity, Mortality Seen in AIHA, Making Case for Early Testing, Long-Term Study Finds

Thomas R. Collins
Published: 2024
Abstract
January 2025
View News titled, Considerable Morbidity, Mortality Seen in AIHA, Making Case for Early Testing, Long-Term Study Finds
News

Pirtobrutinib Combinations Effective in Small Study

Thomas R. Collins
Published: 2024
Abstract
December Supplement 2024
View News titled, Pirtobrutinib Combinations Effective in Small Study
News

MRD Helpful in Predicting Progression-Free Survival in CLL

Thomas R. Collins
Published: 2024
Abstract
December Supplement 2024
View News titled, MRD Helpful in Predicting Progression-Free Survival in CLL
News

A Trial of Nanoparticle Tracking of CAR-T Therapy Distribution in Patients with Extramedullary Myeloma Shows Promise

Thomas R. Collins
Published: 2024
Abstract
January 2025
View News titled, A Trial of Nanoparticle Tracking of CAR-T Therapy Distribution in Patients with Extramedullary Myeloma Shows Promise
News

MGUS Risk Assessment Over Time Yields Benefits, Study Shows

Thomas R. Collins
Published: 2024
Abstract
December 2024
View News titled, MGUS Risk Assessment Over Time Yields Benefits, Study Shows
News

Superhero and Villain

Thomas R. Collins
Published: 2024
Abstract
December 2024 Although shows like Supacell bring awareness to sickle cell disease, many media depictions contribute to stereotypes and misinformation.
View News titled, Superhero and Villain
News

Venetoclax Effective for Bridging to Transplant in R/R AML, Study Suggests

Thomas R. Collins
Published: 2024
Abstract
Mid-November 2024
View News titled, Venetoclax Effective for Bridging to Transplant in R/R AML, Study Suggests